Skip to main content
. 2021 Dec 2;12:21501327211056800. doi: 10.1177/21501327211056800

Table 3.

In-Hospital Management, Complications, and Outcomes of Patients.

Authors In-hospital management Complications Outcomes
Cizgic et al 13 Furosemide, angiotensin converting enzyme (ACE) inhibitor and, beta-blocker along with Covid-19 specific therapy ARDS Transfer red back to Covid19 center
Yokoo et al 14 Antibiotics, steroids Discharged
Pietsch et al 15 N/A N/R N/R
Pavon et al 16 Piperacillin-tazobactam, catecholamine, Intubated N/R Discharged
Khatri et al 17 Hydroxychloroquine (400 mg twice on the first day, succeeded by 200 mg twice a day for 4 days), IV azithromycin, IV vancomycin, IV cefepime, and methylene blue infusion, IV methylprednisolone (200 mg/d) on 3 day, dobutamine, vasopressin, and norepinephrine Cardiogenic and distributive shock, with multi-organ failure Died on day 4
Hussain et al 18 Remdesivir, hydroxychloroquine and azithromycin, and Indomethacin 7th day, methylprednisolone and colchicine, mechanical ventilation ARDS on 2nd day N/R
Dalen et al 19 IV fluids, norepinephrine, and dobutamine Cardiogenic shock Recovered
Zeng et al 20 High-flow oxygen, lopinavir-ritonavir, interferon α-1b, immunoglobulin, piperacillin-tazobactam, and continuous renal replacement therapy, IV methylprednisolone, vasopressors used from day 26, ECMO on day 11 Cardiogenic shock on day 11, Septic shock on day 26, ARDS day 1 Passed away on day 33
Doyen et al 21 Aspirin, fondaparinux, IV hydrocortisone for 9 days, Mechanical ventilation ARDS Discharged from ICU after 3 weeks
Faircloth et al 22 Norepinephrine, vasopressin, dobutamine, and methylprednisolone Discharged
Coyle et al 23 Hydroxychloroquine, azithromycin, ceftriaxone, and tocilizumab, IV methylprednisolone 500 mg daily x 4 days, followed by decreasing dose and, colchicine, milrinone day 4, norepinephrine day 4, mechanical ventilation on day 3 ARDS on day 3, Cardiogenic shock on day 4 Discharged on day 19
Luetkens et al 24 N/R N/R N/R
Jain et al 25 Vasoactive drugs, vancomycin and cefepime, IVIG, pulse dose steroids, and mechanical ventilation. Cardiogenic shock and multi-organ failure Discharged on day 46
Renal replacement therapy for acute kidney injury and N-acetylcysteine for acute liver injury, NA NA
Mustafa et al 26 Aspirin, unfractionated heparin and nitroglycerin infusion for acute coronary syndrome. N/R Improvement in symptoms over the next few days
Azithromycin and hydroxychloroquine
Mansoor et al 27 Vancomycin, meropenem, chloroquine, and azithromycin, norepinephrine, phenylephrine, vasopressin, diuretics, and subcutaneous heparin Multi-organ system failure and pulseless electrical activity. Mortality on day 6 in ICU
Al-assaf et al 28 Enoxaparin, amlodipine, and scheduled a permanent pacemaker implant. Discharged in stable condition.
Khalid et al 29 Tocilizumab ( 2-dose of 480 mg and 240 mg), intravenous immunoglobulin (25 g for 5 days), ceftriaxone, cefdinir, and cefepime, norepinephrine, Intubated Cardiogenic shock, ARDS Recovered
Inciardi et al 30 Hydroxychloroquine (200 mg 2 times a day ), lopinavir/ritonavir (250 every 12 h), kanrenone (50 mg), furosemide(25-50 mg), and bisoprolo(2.5 mg)l, IV methylprednisolone 1 mg/kg for 3 days, dobutamine Cardiogenic shock on day 1 Recovered
Fried et al 31 Intraaortic baloon pump was inserted and dobutamine infusion Cardiogwnic shock Discharge
Wehit et al 32 Ampicillin/sulbactam, liponavir/ritonavir and hydroxychloroquine, orotracheal intubation and mechanical ventilation On day 15, bacteraemic sepsis and multi-organ failure Patient was still in the intensive care unit
Butler et al 33 Rehabilitation N/R N/R
Lagana et al 34 Methyl prednisolone (100%), Ace Inhibitor (75%) Cardiogenic shock (33.33%) 3(25%)
Kallel et al 35 Oxygen therapy with a high concentration mask (10 litters/minute) for acute respiratory failure on admission.
Dobutamine (5 γ/kg/min) and noradrenaline (3 mg/h).
One dose of 80mg of Tocilizumab), corticosteroid, and azithromycin; (500mg the first day then 25 mg/day for 4 days).
N/R Discharged 7 days later in-patient management
Fath et al 37 Aspirin and ticagrelor, along with the heparin infusion and inotropic support with norepinephrine, vasopressin, and dobutamine for acute coronary syndrome. Cardiac arrest Died
Dabbagh et al 38 Hydroxychloroquine, glucocorticoids, and colchicine; Intubated. Discharged
Irabien-Ortiz et 39 Immunoglobulins (80 mg/day), interferon-B (0.25 mg every 48 h) and ritonavir/lopinavir, IV methylprednisolone 500 mg daily at decreasing doses for 14 days, and norepinephrine, ECMO Cardiogenic shock on day 1 N/R
Albert et al 40 Tocilizumab, Methyprednizone, IV immunoglobulin, Inotropes, ECMO. Discharged
Escher et al 41 Cyclophosphamide and steroids. Recovered
Ford et al 42 Amiodarone load, ceftriaxone/azithromycin, tissue plasminogen activator, warfarin. Recovered and discharged
Gauchotte et al 43 Vasopressors, Inotropic support, ECMO, intubation. N/R Deceased at 6th day of hospitalization
Hua et al 44 Vasopressors Cardiogenic shock day 1 Recovered
Jacobs et al 45 Hydroxychloroquine, azithromycin, noradrenaline, adrenaline, and dobutamine Refractory shock Died
Labani et al 46 N/R Recovered and discharged
Spano et al 47 N/R N/R N/R
Tavazzi et al 48 Adrenaline (0.07 μg/kg/mi n), and noradren aline (0.1 μg/kg/mi n), ECMO and IABP Cardiogenic shock on day 1 and septic shock Died
Trogen et al 49 Hydroxychloroquine, piperacillin/tazobactam, enoxaparin Septic shock Discharged
Varga et al 50 N/R N/R Died
Warchoł et al 51 Azithromycin, oseltamivir, magnesium, and amiodarone N/R N/R
Sardari et al 52 Bisoprolol and lisinopril Plueritic chest pain N/R
Dahl et al 53 Cefotaxime, clindamycin,3 L/min- oxygen, Furosemide, norepinephrine, Continuous positive airway pressure respiratory distress,right side bell’s palsy Discharged on day 11
Hu et al 54 methylprednisolone,immunoglobulin,norepinephrine,toracemide,furosemidemilrinone,piperacillin,sulbactam, pantoprazole cardiogenic shock and pulmonary infection Discharge
Volis et al 55 N/R Pleuritic chest pain, dyspnea Discharge
Besler et al 56 Hydroxychloroquine, azithromycin, ceftriaxone, tigecycline, favipiravir, colchicine chest pain Discharged on day 7
Gaine et al 57 Diuretics, rate-control agents, anticoagulants, ACE inhibitor, mineralocorticoid antagonist Heart failure discharge
Sheikh et al 58 Metoprolol, lisinopril, low-dose aspirin, hydrochlorthiazide, desmopressin Diabetes insipidus Discharge
Salamanca et al 59 Dobutamine, norepinephrine, methylprednisolone, tocilizumab, hydroxychloroquine, azithromycin, lopinavir-ritonavir, temporary pacemaker, extracorporeal membrane oxygenation, intra-aortic balloon pump Cardiogenic shock Discharge
Naneishvili et al 60 Methylprednisolone, dobutamine, amiodarone, milrinone, norepinephrine, antibiotics cardiogenic shock Discharge
Kim et al 61 N/R N/R N/R
Nikoo et al 62 Amiodarone, dexamethasone, standard heart failure therapies (details n/r),therapeutic anticoagulation, temporary pacemaker Cardiogenic shock Discharge
Long ma et al 3 NA NA NA
Sala et al 63 Lopinavir, Hydroxychloroquine Chest Pain, dyspnoea Discharge
Yuan et al 64 N/R Chest Pain Discharge
Warchol et al Azithromycin, oseltamivir Hemodynamically unstable N/R
Asif and Ali 65 P1: Aspirin, clopidogrel and heparin, azythromycin, hydroxychloroquine, tocilizumab, merooenum, norepinephrine. P2: Azythromycin, tocilizumab, nor epinephrine, midazolam P1: ARDS, P2: ARDS P1: Died, P2: ICI
Khalid et al 66 P1: Aspirin, clopidogrel and diuretics P2: Methylprednisone, colchicine P1: N/R. P2: Refractory shock P1: Discharge, P2: Discharge
Ng et al 67 N/R N/R N/R
Jirak et al 68 Catecholamine, extracorporeal membrane oxygen therapy, Antibiotics. ARDS, N/R
Yan et al 69 N/R N/R N/R
Kunal S et al 70 Hydroxychloroquine, Azithromycin N/R 57.% Died